Doctor profile · Federal record

Dr. Ludmila Martin, MD

Medical Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Internal Medicine Physician · Tacoma, WA

  • NPI 1568653509
  • Accepts Medicare
  • MIPS 77.2 / 100 · 2023
  • 19 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1624 S I St, Suite 305
Tacoma, WA 984055016
(253) 428-8700
fax (253) 383-3376
Mailing address
2920 S Meridian, Suite 100
Puyallup, WA 983731428

Credentials & registration

NPPES · NUCC
NPI registered
August 2007 — 19 yrs on file
Profile last updated
November 4, 2014
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (3)
Washington #60384465 · Washington #MD60384465 · Ohio #35.094489
Medicaid
WA #2030126

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1568653509. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
173,617
Distinct HCPCS
10
Medicare allowed
$1,392,025
HCPCS Description Services Patients Avg allowed
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 47,220 33 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 33,150 43 $0
J1453 Injection, fosaprepitant, 1 mg 24,150 48 $0
J9263 Injection, oxaliplatin, 0.5 mg 13,400 12 $0
J9271 Injection, pembrolizumab, 1 mg 13,300 19 $44
J9299 Injection, nivolumab, 1 mg 7,960 12 $30
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 6,160 12 $3
J9267 Injection, paclitaxel, 1 mg 5,628 12 $0
J0897 Injection, denosumab, 1 mg 3,360 15 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,476 89 $0

In context: peer comparison

Among 5 peers in this city , average services per provider: 1,883. This provider delivers 92× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,467
Transactions
32
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Ipsen Biopharmaceuticals, Inc 16 $2,140.88
Merck Sharp & Dohme LLC 3 $54.44
Daiichi Sankyo Inc. 2 $47.41
Sumitomo Pharma America, Inc. 2 $38.22
BeiGene USA, Inc. 1 $25.34
Novartis Pharmaceuticals Corporation 1 $24.64
GlaxoSmithKline, LLC. 1 $21.99
Genmab U.S., Inc. 1 $21.57
E.R. Squibb & Sons, L.L.C. 1 $20.65
Celgene Corporation 1 $19.88
Gilead Sciences, Inc. 1 $19.20
ABBVIE INC. 1 $16.75
AstraZeneca Pharmaceuticals LP 1 $16.03

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$1,725
Food and Beverage
$700
Travel and Lodging
$42

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
803
Patients
220
Total drug cost
$150,545
Drug Type Claims Patients Total cost
Gabapentin Generic 114 30 $2,485
Levothyroxine Sodium Generic 72 16 $641
Oxycodone Hcl Generic 72 30 $2,073
Creon (Lipase/Protease/Amylase) Brand 61 15 $100,456
Potassium Chloride Generic 54 28 $1,311
Furosemide Generic 48 20 $141
Metoclopramide Hcl Generic 48 11 $491
Acyclovir Generic 47 0 $1,354
Dexamethasone Generic 47 26 $1,027
Xarelto (Rivaroxaban) Brand 45 12 $33,812

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ludmila Martin's medical specialty?
Dr. Ludmila Martin practices Medical Oncology Physician in Tacoma, WA.
Where does Dr. Ludmila Martin practice?
Dr. Ludmila Martin practices at 1624 S I St, Tacoma, WA 984055016. Office phone: 2534288700.
What is Dr. Ludmila Martin's NPI?
Dr. Ludmila Martin's National Provider Identifier (NPI) is 1568653509, issued by NPPES.
Does Dr. Ludmila Martin accept Medicare assignment?
Yes. Dr. Ludmila Martin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ludmila Martin commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.